Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 4/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | CA12 | O43570 | 3/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CA4 | P22748 | 3/20 | 0.52 |
| ▸ | CA6 | P23280 | 3/20 | 0.52 |
| ▸ | CA5A | P35218 | 3/20 | 0.52 |
| ▸ | CA7 | P43166 | 3/20 | 0.52 |
| ▸ | CA9 | Q16790 | 3/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.52 |
| ▸ | F13A1 | P00488 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | THPO | P40225 | 2/20 | 0.52 |
| ▸ | CA3 | P07451 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7517784 | 0.98 | PAOX (0.77) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL25229942 | 0.98 | PAOX (0.77) | PAOXKDM4EMAPK1HIF1ACA12 | |
| Hydrochloric Acid SCHEMBL15641673 | 0.96 | PAOX (0.74) | PAOXKDM4EMAPK1HIF1ACA12 | |
| Spermidine SCHEMBL10954114 | 0.96 | PAOX (0.80) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL193116 | 0.96 | PAOX (0.73) | PAOXKDM4EMAPK1HIF1ACA12 | |
| Hydrochloric Acid SCHEMBL27789136 | 0.94 | PAOX (0.70) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL22171096 | 0.94 | PAOX (0.69) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL22171088 | 0.94 | PAOX (0.69) | PAOXKDM4EMAPK1HIF1ACA12 | |
| Spermine SCHEMBL25409776 | 0.94 | PAOX (0.76) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL14259507 | 0.94 | PAOX (0.69) | PAOXKDM4EMAPK1HIF1ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 930 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099467-A1 | COMPOSITION FOR USE IN PROMOTING BRAIN DEVELOPMENT AND FUNCTIONING | Société des Produits Nestlé S.A. (CH) | 2026-05-15 | — | — | WO | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| US-20260051387-A1 | METABOLOMIC ANALYSIS OF PERITONEAL DIALYSIS EFFLUENT | FRESENIUS MEDICAL CARE HOLDINGS, INC. (US) | 2026-02-19 | — | — | US | claimed |
| EP-4603107-A1 | BIOORTHOGONAL, ANILINIUM BASED CLEAVABLE TETRAZINES | University of Copenhagen (DK) | 2025-08-20 | — | — | EP | claimed |
| EP-4591872-A1 | COMPOSITION COMPRISING LACTOBACILLUS PLANTARUM STRAIN FOR IMPROVING INTESTINAL METABOLITE COMPOSITION | Gi Biome Inc. (KR) | 2025-07-30 | — | — | EP | claimed |
| EP-4551232-A1 | METABOLOMIC IMPROVEMENTS USING RESISTANT STARCH SUPPLEMENTATION | Mcpharma Biotech Inc. (CA) | 2025-05-14 | — | — | EP | claimed |
| EP-4518832-A1 | CHONDROITIN- AND COLLAGEN PEPTIDE-BASED METHODS FOR SLOWING DOWN AGING AND EXTENDING LIFESPAN | Ageless Sciences, Inc. (US) | 2025-03-12 | — | — | EP | claimed |
| CN-119173247-A | Methods for slowing aging and prolonging life based on chondroitin and collagen peptides | 不老科学公司 | 2024-12-20 | — | — | CN | claimed |
| EP-4442264-A1 | THERAPEUTIC AGENT FOR DIARRHEA AND METHOD FOR TREATING BOVINE DIARRHEA | Tohoku University (JP) | 2024-10-09 | — | — | EP | claimed |
| CN-118688333-A | Marker related to allergic rhinitis and kit thereof | 厦门市迈理奥科技有限公司 | 2024-09-24 | — | — | CN | claimed |
| EP-1093383-A1 | DRUG DELIVERY SYSTEM COMPRISING A HOMEOBOX PEPTIDE | Cyclacel Limited (GB) | 2001-04-25 | — | — | EP | claimed |
| US-6172261-B1 | BIOSYNTHESIS USING CHAIN EXTENSION | ORIDIGM CORPORATION | 2001-01-09 | — | — | US | claimed |
| WO-2000029427-A2 | ANTENNAPEDIA HOMEODOMAIN HELIX 3 DERIVED TRANSLOCATION VECTORS | CYCLACEL LIMITED (GB) | 2000-05-25 | — | — | WO | claimed |
| EP-1001927-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2000-05-24 | — | — | EP | claimed |
| WO-2000001417-A1 | DELIVERY SYSTEM | CYCLACEL LIMITED (GB) | 2000-01-13 | — | — | WO | claimed |
| WO-1999003823-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 1999-01-28 | — | — | WO | claimed |
| EP-0297533-B1 | Novel acetylpolyamine amidohydrolase | KYOWA HAKKO KOGYO KK (JP) | 1994-06-01 | — | — | EP | claimed |
| EP-0568338-A2 | Methods for the use of spermidine/spermine N'-acetyltransferase as a progonostic indicator and/or a tumor response marker | HEALTH RESEARCH, INC. (US) | 1993-11-03 | — | — | EP | claimed |
| US-4981788-A | BIOSYNTHESIS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-01-01 | — | — | US | claimed |
| EP-0297533-A2 | Novel acetylpolyamine amidohydrolase | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1989-01-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | GLS, AADAT, FGF23 | PAOX 4517/4885KDM4E 124/4885MAPK1 1697/4885 |
| US-20260051387-A1 | METABOLOMIC ANALYSIS OF PERITONEAL DIALYSIS EFFLUENT | SLC43A1, SLC14A1, SLC1A5 | PAOX 2238/4885KDM4E 2100/4885MAPK1 3489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.